These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31842115)

  • 1. Molecular Determinants of Statin-sensitivity in Cancer.
    Fatehi Hassanabad A; Wong JVS
    Am J Clin Oncol; 2020 Mar; 43(3):160-162. PubMed ID: 31842115
    [No Abstract]   [Full Text] [Related]  

  • 2. The pleiotropic effects and therapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in malignancies: a comprehensive review.
    Zeichner S; Mihos CG; Santana O
    J Cancer Res Ther; 2012; 8(2):176-83. PubMed ID: 22842358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel prospects of statins as therapeutic agents in cancer.
    Pisanti S; Picardi P; Ciaglia E; D'Alessandro A; Bifulco M
    Pharmacol Res; 2014 Oct; 88():84-98. PubMed ID: 25009097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and cancer: current and future prospects.
    Osmak M
    Cancer Lett; 2012 Nov; 324(1):1-12. PubMed ID: 22542807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
    Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
    Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.
    Longo J; Mullen PJ; Yu R; van Leeuwen JE; Masoomian M; Woon DTS; Wang Y; Chen EX; Hamilton RJ; Sweet JM; van der Kwast TH; Fleshner NE; Penn LZ
    Mol Metab; 2019 Jul; 25():119-130. PubMed ID: 31023626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The anticancer properties of statins].
    Sławińska A; Kandefer-Szerszeń M
    Postepy Hig Med Dosw (Online); 2008 Aug; 62():393-404. PubMed ID: 18688209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of statins in cancer prevention and treatment.
    Stamm JA; Ornstein DL
    Oncology (Williston Park); 2005 May; 19(6):739-50; discussion 753-4. PubMed ID: 15971450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological actions of statins: a critical appraisal in the management of cancer.
    Gazzerro P; Proto MC; Gangemi G; Malfitano AM; Ciaglia E; Pisanti S; Santoro A; Laezza C; Bifulco M
    Pharmacol Rev; 2012 Jan; 64(1):102-46. PubMed ID: 22106090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
    Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
    Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antitumor activity of cerivastatin, a novel and potent HMG-CoA reductase inhibitor.
    Feleszko W; Mlynarczuk I; Nowis D
    FEBS Lett; 2001 Aug; 503(2-3):219-20. PubMed ID: 11526915
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: The association between statins and cancer incidence in a veterans population.
    Platz EA
    J Natl Cancer Inst; 2008 Jul; 100(13):972; author reply 973-4. PubMed ID: 18577751
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: The association between statins and cancer incidence in a veterans population.
    Ravnskov U
    J Natl Cancer Inst; 2008 Jul; 100(13):972-3; author reply 973-4. PubMed ID: 18577750
    [No Abstract]   [Full Text] [Related]  

  • 14. Is statin use really associated with efficacy of rituximab?
    Asai H; Yokoyama M; Terui Y; Ennishi D; Takeuchi K; Hatake K
    J Clin Oncol; 2010 Aug; 28(24):e424-5; author reply e427-8. PubMed ID: 20567023
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells.
    Tapia-Pérez JH; Kirches E; Mawrin C; Firsching R; Schneider T
    Cancer Chemother Pharmacol; 2011 May; 67(5):1193-201. PubMed ID: 21120479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of statins on the chemoresistance-The antagonistic drug-drug interactions versus the anti-cancer effects.
    Ahmadi Y; Karimian R; Panahi Y
    Biomed Pharmacother; 2018 Dec; 108():1856-1865. PubMed ID: 30372891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between statins and cancer incidence in a veterans population.
    Farwell WR; Scranton RE; Lawler EV; Lew RA; Brophy MT; Fiore LD; Gaziano JM
    J Natl Cancer Inst; 2008 Jan; 100(2):134-9. PubMed ID: 18182618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin and celecoxib: a future role in cancer chemoprevention.
    Kapoor S
    Int J Cancer; 2008 Aug; 123(3):737. PubMed ID: 18491399
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells.
    Taylor-Harding B; Orsulic S; Karlan BY; Li AJ
    Gynecol Oncol; 2010 Dec; 119(3):549-56. PubMed ID: 20837358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins in tumor suppression.
    Sassano A; Platanias LC
    Cancer Lett; 2008 Feb; 260(1-2):11-9. PubMed ID: 18180097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.